Goldman Sachs's Jami Rubin says AbbVie's pipeline assets make it a stealth competitor.
The commericalization/development deal covers up to six anti-cancer assets, and gives OncoMed a 50/50 US partnership over the experimental monoclonal antibody demcizumab.
Sanofi top-lined positive clinical data today from its investigational basal insulin, as it seeks to defend its position in this fast-growing segment.
Chronic disease patients seek online support and information, and show little love for branded websites.
Getting to an integrated mar-comms model isn't easy. Addressing your agency's lack of digital skills is a good start.
The company's new president and possible CEO is expected to have significant latitude to change things.
The trio will focus on using immune systems to attack cancer.
AstraZeneca has been awarded $76 million in damages in a ruling over Apotex's sales of a generic version of Prilosec.
Click on the image above to see a gallery of images from the 2013 MM&M Awards dinner
Missed MM&M's recent Skill Sets Live event on Multi-Screen Marketing? We're now giving you a second chance to get up to speed! Click here to access this insightful e-book with all the key take-aways.